ID: ALA284264

Max Phase: Preclinical

Molecular Formula: C21H26O2

Molecular Weight: 310.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1=C(/C=C/C(C)=C/c2ccc(C(=O)O)cc2)C(C)(C)CCC1

Standard InChI:  InChI=1S/C21H26O2/c1-15(14-17-8-10-18(11-9-17)20(22)23)7-12-19-16(2)6-5-13-21(19,3)4/h7-12,14H,5-6,13H2,1-4H3,(H,22,23)/b12-7+,15-14+

Standard InChI Key:  NNTWECUMTLRLCK-SEGNDCOSSA-N

Associated Targets(Human)

Retinoic acid receptor alpha 1324 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoic acid receptor beta 1232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoic acid receptor gamma 1154 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoid X receptor alpha 3637 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cricetinae gen. sp. 3197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ornithine decarboxylase 263 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.44Molecular Weight (Monoisotopic): 310.1933AlogP: 5.87#Rotatable Bonds: 4
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.12CX Basic pKa: CX LogP: 5.55CX LogD: 2.46
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.71Np Likeness Score: 1.18

References

1. Dawson MI, Chan R, Hobbs PD, Chao WR, Schiff LJ..  (1983)  Aromatic retinoic acid analogues. 2. Synthesis and pharmacological activity.,  26  (9): [PMID:6887203] [10.1021/jm00363a013]
2. Dawson MI, Hobbs PD, Derdzinski K, Chan RL, Gruber J, Chao WR, Smith S, Thies RW, Schiff LJ..  (1984)  Conformationally restricted retinoids.,  27  (11): [PMID:6208361] [10.1021/jm00377a022]
3. Dawson MI, Chan RL, Derdzinski K, Hobbs PD, Chao WR, Schiff LJ..  (1983)  Synthesis and pharmacological activity of 6-[(E)-2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethen-1-yl]- and 6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acids.,  26  (11): [PMID:6195339] [10.1021/jm00365a021]
4. Jong L, Lehmann JM, Hobbs PD, Harlev E, Huffman JC, Pfahl M, Dawson MI..  (1993)  Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.,  36  (18): [PMID:8410972] [10.1021/jm00070a003]
5. Dawson MI, Hobbs PD, Chan RL, Chao WR, Fung VA..  (1981)  Aromatic retinoic acid analogues. Synthesis and pharmacological activity.,  24  (5): [PMID:7241516] [10.1021/jm00137a019]

Source